Tunis Sean R, Carino Tanisha V, Williams Reginald D, Bach Peter B
Center for Medical Technology Policy, San Francisco, CA, USA.
Health Aff (Millwood). 2007 Mar-Apr;26(2):w140-9. doi: 10.1377/hlthaff.26.2.w140. Epub 2007 Jan 26.
Health policy and financing reforms place increasing emphasis on the ability of doctors and patients to make informed, cost-conscious care decisions. The federal government is supporting new initiatives in Medicare to increase the supply of reliable information on the benefits and risks of health care technologies. Medicare also is working with the Agency for Healthcare Research and Quality (AHRQ) to evaluate the comparative effectiveness of prescription drugs and other items or services. The value of these efforts will depend on coordination among individuals and institutions in the public and private sectors; clarity about focus, purpose, and priorities; and adequate and reliable long-term funding.
卫生政策与融资改革越来越强调医生和患者做出明智的、注重成本的医疗决策的能力。联邦政府正在支持医疗保险领域的新举措，以增加有关医疗技术益处和风险的可靠信息供应。医疗保险还在与医疗保健研究与质量局（AHRQ）合作，评估处方药及其他项目或服务的比较效果。这些努力的成效将取决于公共和私营部门的个人与机构之间的协调；重点、目的和优先事项的明确性；以及充足且可靠的长期资金。
